
LINK . SPRINGER . COM {
}
Title:
All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells | BMC Cancer
Description:
Background The enrichment of cancer stem cell-like cells (CSCs) has been considered to be responsible for tumor progression after an initial response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs) in patients with non-small cell lung adenocarcinoma (NSCLC/ADC). CSCs with ALDH1A1bright /CD44high expression contribute to the TKIs resistance in NSCLC/ADC cells. All-trans retinoic acid (ATRA) has been shown to be a potential targeted therapy against CSCs due to its ability to inhibit ALDH1A1 activity. We therefore investigated whether ATRA could circumvent the resistance to improve the response to gefitinib in NSCLC/ADC cells. Methods Treatment of NSCLC/ADC A549 and H1650 cells with gefitinib enriched the gefitinib surviving cells (GSCs). The expression of ALDH1A1 and CD44 and the IC50 values for gefitinib were determined by flow cytometry (FCM) and crystal violet assay in GSCs and ATRA-treated GSCs, respectively. Using DEAB as the positive control, direct inhibitory effect of ATRA on ALDH1A1 activity was determined by ALDEFLUOR assay, Results GSCs showed higher expression of ALDH1A1 and CD44 and IC50 values for gefitinib than their respective parental cells, suggesting that gefitinib can lead to propagation of CSC-enriched gefitinib-resistant cells. Treatment with ATRA was found to significantly reduce the increased expression of ALDH1A1 and CD44 and the IC50 values for gefitinib in A549GSC and H1650GSC cells, and ATRA could directly inhibit active ALDH1A1 as compared to DEAB. Conclusion Our findings suggest that combination treatment with ATRA prevents gefitinib-induced enrichment of ALDH1A1bright/CD44high CSCs and enhances gefitinib-induced growth inhibition of NSCLC/ADC cells.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {š}
- Science
- Education
- Health & Fitness
Content Management System {š}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {š}
What is the average monthly size of link.springer.com audience?
š Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {šø}
We can't tell how the site generates income.
Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.
Keywords {š}
cancer, cells, cell, pubmed, article, gefitinib, lung, atra, resistance, cas, google, scholar, aldha, expression, acid, retinoic, nsclc, egfr, cscs, growth, stem, treatment, agsc, data, receptor, hgsc, egfrtkis, inhibition, rarβ, activity, nonsmall, central, mutation, factor, nsclcadc, fig, apoptosis, tumor, response, patients, celllike, kinase, control, acquired, alltrans, inhibitors, shown, therapy, showed, compared,
Topics {āļø}
n-[3-chloro-4-fluorophenyl]-7-methoxy-6-[3-morpholinopropoxy]quinazolin-4- amine egfr-tki-resistant aldh1a1bright/cd44high csc gadd153-ccaat-enhancing binding protein-β net/cancer-types/lung-cancer ccaat/enhancer-binding protein beta jun n-terminal kinase csc-enriched gefitinib-resistant cells csc cell-mediated resistance gsc-enriched gefitinib-resistant cells egfr-mutant lung cancers ccaat-enhancing binding protein drug-resistant cancer cells article download pdf small-cell lung cancer reduce csc-mediated resistance aldh1a1bright/cd44high cell population egfr-tkis exposure influences tyrosine kinase inhibitors therapeutic anti-csc trans retinoic acid trans-retinoic acid receptor class-selective retinoids retinoic acid receptor potential therapeutic targets egfr-tkis maintenance therapy tris/acetate/edta pcr cell-mediated resistance aldh1a1-negative cell population cancer therapies egfr/wnt signaling pathways retinoic acid signaling lung cancer stem aldehyde dehydrogenase inhibitors cancer stem cell cancer stem cell full access high atra levels quantitative fluorescence pcr gata-binding factor 6 retinoic acid receptors cell death dis cancer drug resistance short-term gefitinib treatment promising therapeutic strategy aldh1a1bright/cd44high cscs linked tumor stem cell cancer stemness induced cancer stem cells aldh/nrf2 signaling privacy choices/manage cookies
Schema {šŗļø}
WebPage:
mainEntity:
headline:All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells
description:The enrichment of cancer stem cell-like cells (CSCs) has been considered to be responsible for tumor progression after an initial response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs) in patients with non-small cell lung adenocarcinoma (NSCLC/ADC). CSCs with ALDH1A1bright /CD44high expression contribute to the TKIs resistance in NSCLC/ADC cells. All-trans retinoic acid (ATRA) has been shown to be a potential targeted therapy against CSCs due to its ability to inhibit ALDH1A1 activity. We therefore investigated whether ATRA could circumvent the resistance to improve the response to gefitinib in NSCLC/ADC cells. Treatment of NSCLC/ADC A549 and H1650 cells with gefitinib enriched the gefitinib surviving cells (GSCs). The expression of ALDH1A1 and CD44 and the IC50 values for gefitinib were determined by flow cytometry (FCM) and crystal violet assay in GSCs and ATRA-treated GSCs, respectively. Using DEAB as the positive control, direct inhibitory effect of ATRA on ALDH1A1 activity was determined by ALDEFLUOR assay, GSCs showed higher expression of ALDH1A1 and CD44 and IC50 values for gefitinib than their respective parental cells, suggesting that gefitinib can lead to propagation of CSC-enriched gefitinib-resistant cells. Treatment with ATRA was found to significantly reduce the increased expression of ALDH1A1 and CD44 and the IC50 values for gefitinib in A549GSC and H1650GSC cells, and ATRA could directly inhibit active ALDH1A1 as compared to DEAB. Our findings suggest that combination treatment with ATRA prevents gefitinib-induced enrichment of ALDH1A1bright/CD44high CSCs and enhances gefitinib-induced growth inhibition of NSCLC/ADC cells.
datePublished:2020-04-15T00:00:00Z
dateModified:2020-04-15T00:00:00Z
pageStart:1
pageEnd:9
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s12885-020-06818-0
keywords:
All-trans retinoic acid
ALDH1A1
CD44
EGFR tyrosine kinase inhibitors
Non-small cell lung adenocarcinoma
Cancer Research
Oncology
Surgical Oncology
Health Promotion and Disease Prevention
Biomedicine
general
Medicine/Public Health
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_Fig4_HTML.png
isPartOf:
name:BMC Cancer
issn:
1471-2407
volumeNumber:20
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Wenxiu Yao
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Liyang Wang
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Huan Huang
affiliation:
name:Wuming Hospital Affiliated to Guangxi Medical University
address:
name:Department of Medical oncology, Wuming Hospital Affiliated to Guangxi Medical University, Nanning, China
type:PostalAddress
type:Organization
type:Person
name:Xin Li
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Pinjia Wang
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Kun Mi
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Jia Cheng
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Huifen Liu
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Cuirong Gu
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Lingxiao Huang
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Jianming Huang
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells
description:The enrichment of cancer stem cell-like cells (CSCs) has been considered to be responsible for tumor progression after an initial response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs) in patients with non-small cell lung adenocarcinoma (NSCLC/ADC). CSCs with ALDH1A1bright /CD44high expression contribute to the TKIs resistance in NSCLC/ADC cells. All-trans retinoic acid (ATRA) has been shown to be a potential targeted therapy against CSCs due to its ability to inhibit ALDH1A1 activity. We therefore investigated whether ATRA could circumvent the resistance to improve the response to gefitinib in NSCLC/ADC cells. Treatment of NSCLC/ADC A549 and H1650 cells with gefitinib enriched the gefitinib surviving cells (GSCs). The expression of ALDH1A1 and CD44 and the IC50 values for gefitinib were determined by flow cytometry (FCM) and crystal violet assay in GSCs and ATRA-treated GSCs, respectively. Using DEAB as the positive control, direct inhibitory effect of ATRA on ALDH1A1 activity was determined by ALDEFLUOR assay, GSCs showed higher expression of ALDH1A1 and CD44 and IC50 values for gefitinib than their respective parental cells, suggesting that gefitinib can lead to propagation of CSC-enriched gefitinib-resistant cells. Treatment with ATRA was found to significantly reduce the increased expression of ALDH1A1 and CD44 and the IC50 values for gefitinib in A549GSC and H1650GSC cells, and ATRA could directly inhibit active ALDH1A1 as compared to DEAB. Our findings suggest that combination treatment with ATRA prevents gefitinib-induced enrichment of ALDH1A1bright/CD44high CSCs and enhances gefitinib-induced growth inhibition of NSCLC/ADC cells.
datePublished:2020-04-15T00:00:00Z
dateModified:2020-04-15T00:00:00Z
pageStart:1
pageEnd:9
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s12885-020-06818-0
keywords:
All-trans retinoic acid
ALDH1A1
CD44
EGFR tyrosine kinase inhibitors
Non-small cell lung adenocarcinoma
Cancer Research
Oncology
Surgical Oncology
Health Promotion and Disease Prevention
Biomedicine
general
Medicine/Public Health
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_Fig4_HTML.png
isPartOf:
name:BMC Cancer
issn:
1471-2407
volumeNumber:20
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Wenxiu Yao
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Liyang Wang
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Huan Huang
affiliation:
name:Wuming Hospital Affiliated to Guangxi Medical University
address:
name:Department of Medical oncology, Wuming Hospital Affiliated to Guangxi Medical University, Nanning, China
type:PostalAddress
type:Organization
type:Person
name:Xin Li
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Pinjia Wang
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Kun Mi
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Jia Cheng
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Huifen Liu
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Cuirong Gu
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Lingxiao Huang
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Jianming Huang
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:BMC Cancer
issn:
1471-2407
volumeNumber:20
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
name:Wuming Hospital Affiliated to Guangxi Medical University
address:
name:Department of Medical oncology, Wuming Hospital Affiliated to Guangxi Medical University, Nanning, China
type:PostalAddress
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Wenxiu Yao
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Liyang Wang
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Huan Huang
affiliation:
name:Wuming Hospital Affiliated to Guangxi Medical University
address:
name:Department of Medical oncology, Wuming Hospital Affiliated to Guangxi Medical University, Nanning, China
type:PostalAddress
type:Organization
name:Xin Li
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Pinjia Wang
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Kun Mi
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Jia Cheng
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Huifen Liu
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Cuirong Gu
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Lingxiao Huang
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Jianming Huang
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
name:Department of Medical oncology, Wuming Hospital Affiliated to Guangxi Medical University, Nanning, China
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
External Links {š}(197)
- What's the financial outcome of https://www.springernature.com/gp/authors?
- What is the monthly revenue of https://link.springernature.com/home/?
- How much cash flow does https://order.springer.com/public/cart have monthly?
- How much income does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research have?
- How much profit is https://bmccancer.biomedcentral.com/about making per month?
- How much does https://submission.nature.com/new-submission/12885/3 pull in?
- Monthly income for https://www.cancer.net/cancer-types/lung-cancer-non-small-cell/statistics
- How much profit does http://scholar.google.com/scholar_lookup?&title=Statistics%20Approved%20by%20the%20Cancer.%20Net%20Editorial%20Board&publication_year=2019 make?
- What's the income generated by https://doi.org/10.1016%2Fj.ejca.2005.07.031 each month?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16364841
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Mutations%20of%20the%20epidermal%20growth%20factor%20receptor%20in%20non-small%20cell%20lung%20cancer-search%20and%20destroy&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2005.07.031&volume=42&pages=17-23&publication_year=2006&author=Chan%2CSK&author=Gullick%2CWJ&author=Hill%2CME have monthly?
- What is the monthly revenue of https://doi.org/10.1200%2FJCO.2008.21.5541?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19738125
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Randomized%2C%20placebo-%20controlled%2C%20phase%20II%20study%20of%20sequential%20erlotinib%20and%20chemotherapy%20as%20first-line%20treatment%20for%20advanced%20non-small-cell%20lung%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2008.21.5541&volume=27&pages=5080-5087&publication_year=2009&author=Mok%2CTS&author=Wu%2CYL&author=Yu%2CCJ&author=Zhou%2CC&author=Chen%2CYM&author=Zhang%2CL have monthly?
- Find out how much https://doi.org/10.1056%2FNEJMoa040938 earns monthly
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15118073?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Activating%20mutations%20in%20the%20epidermal%20growth%20factor%20receptor%20underlying%20responsiveness%20of%20non-small-cell%20lung%20cancer%20to%20gefitinib&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa040938&volume=350&pages=2129-2139&publication_year=2004&author=Lynch%2CTJ&author=Bell%2CDW&author=Sordella%2CR&author=Gurubhagavatula%2CS&author=Okimoto%2CRA&author=Brannigan%2CBW?
- How much income is https://doi.org/10.1126%2Fscience.1099314 earning monthly?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15118125
- Earnings of http://scholar.google.com/scholar_lookup?&title=EGFR%20mutations%20in%20lung%20cancer%3A%20correlation%20with%20clinical%20response%20to%20gefitinib%20therapy&journal=Science.&doi=10.1126%2Fscience.1099314&volume=304&pages=1497-1500&publication_year=2004&author=Paez%2CJG&author=J%C3%A4nne%2CPA&author=Lee%2CJC&author=Tracy%2CS&author=Greulich%2CH&author=Gabriel%2CS
- How much does https://doi.org/10.1158%2F1078-0432.CCR-06-0714 bring in each month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17020982 pull in?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Analysis%20of%20epidermal%20growth%20factor%20receptor%20gene%20mutation%20in%20patients%20with%20non-small%20cell%20lung%20cancer%20and%20acquired%20resistance%20to%20gefitinib&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-06-0714&volume=12&pages=5764-5769&publication_year=2006&author=Kosaka%2CT&author=Yatabe%2CY&author=Endoh%2CH&author=Yoshida%2CK&author=Hida%2CT&author=Tsuboi%2CM generate?
- What's the monthly money flow for https://doi.org/10.1016%2FS1470-2045%2809%2970364-X?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20022809
- How much does http://scholar.google.com/scholar_lookup?&title=Gefitinib%20versus%20cisplatin%20plus%20docetaxel%20in%20patients%20with%20non-small-cell%20lung%20cancer%20harbouring%20mutations%20of%20the%20epidermal%20growth%20factor%20receptor%20%28WJTOG3405%29%3A%20an%20open%20label%2C%20randomised%20phase%203%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2809%2970364-X&volume=11&pages=121-128&publication_year=2010&author=Mitsudomi%2CT&author=Morita%2CS&author=Yatabe%2CY&author=Negoro%2CS&author=Okamoto%2CI&author=Tsurutani%2CJ pull in monthly?
- What's the financial outcome of https://doi.org/10.1056%2FNEJMoa0909530?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20573926?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Gefitinib%20or%20chemotherapy%20for%20non-small-cell%20lung%20cancer%20with%20mutated%20EGFR&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa0909530&volume=362&pages=2380-2388&publication_year=2010&author=Maemondo%2CM&author=Inoue%2CA&author=Kobayashi%2CK&author=Sugawara%2CS&author=Oizumi%2CS&author=Isobe%2CH?
- What are the total earnings of https://doi.org/10.1056%2FNEJMoa044238?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15728811?
- How much profit does http://scholar.google.com/scholar_lookup?&title=EGFR%20mutation%20and%20resistance%20of%20non-small-cell%20lung%20cancer%20to%20gefitinib&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa044238&volume=352&pages=786-792&publication_year=2005&author=Kobayashi%2CS&author=Boggon%2CTJ&author=Dayaram%2CT generate?
- https://doi.org/10.1158%2F1078-0432.CCR-12-2246 income
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23470965
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3630270 rake in every month?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Analysis%20of%20tumor%20specimens%20at%20the%20time%20of%20acquired%20resistance%20to%20EGFR-TKI%20therapy%20in%20155%20patients%20with%20EGFR-mutant%20lung%20cancers&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-12-2246&volume=19&issue=8&pages=2240-2247&publication_year=2013&author=Yu%2CHA&author=Arcila%2CME&author=Rekhtman%2CN?
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30864018?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Strategies%20to%20overcome%20acquired%20resistance%20to%20EGFR%20TKI%20in%20the%20treatment%20of%20non-small%20cell%20lung%20cancer&journal=Clin%20Transl%20Oncol&doi=10.1007%2Fs12094-019-02075-1&volume=21&issue=10&pages=1287-1301&publication_year=2019&author=Gao%2CJ&author=Li%2CHR&author=Jin%2CC&author=Jiang%2CJH&author=Ding%2CJY have monthly?
- How much does https://doi.org/10.1002%2Fijc.28478 net monthly?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24105655?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Therapy-%20induced%20enrichment%20of%20putative%20lung%20cancer%20stem-like%20cells&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.28478&volume=134&issue=6&pages=1270-1278&publication_year=2014&author=Freitas%2CDP&author=Teixeira%2CCA&author=Santos-Silva%2CF&author=Vasconcelos%2CMH&author=Almeida%2CGM have monthly?
- How much does https://doi.org/10.1038%2Fcddis.2012.93 earn?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22825470?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406592 pull in?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Non-small%20cell%20lung%20cancer%20stem%2F%20progenitor%20cells%20are%20enriched%20in%20multiple%20distinct%20phenotypic%20subpopulations%20and%20exhibit%20plasticity&journal=Cell%20Death%20Dis&doi=10.1038%2Fcddis.2012.93&volume=3&publication_year=2012&author=Akunuru%2CS&author=James%20Zhai%2CQ&author=Zheng%2CY have monthly?
- Monthly income for https://doi.org/10.1371%2Fjournal.pone.0014062
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21124918 have monthly?
- How much cash flow does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988826 have monthly?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Non-small%20cell%20lung%20cancer%20cells%20expressing%20CD44%20are%20enriched%20for%20stem%20cell-like%20properties&journal=PLoS%20One&doi=10.1371%2Fjournal.pone.0014062&volume=5&issue=11&publication_year=2010&author=Leung%2CEL&author=Fiscus%2CRR&author=Tung%2CJW&author=Tin%2CVP&author=Cheng%2CLC&author=Sihoe%2CAD
- Check the income stats for https://doi.org/10.1158%2F0008-5472.CAN-12-4136
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23542356 net monthly?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506773 generate monthly?
- http://scholar.google.com/scholar_lookup?&title=Acquired%20resistance%20to%20EGFR%20inhibitors%20is%20associated%20with%20a%20manifestation%20of%20stem%20cell-like%20properties%20in%20cancer%20cells&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-12-4136&volume=73&issue=10&pages=3051-3061&publication_year=2013&author=Shien%2CK&author=Toyooka%2CS&author=Yamamoto%2CH's revenue stream
- How much profit is https://doi.org/10.1093%2Fannonc%2Fmdx703 making per month?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29462254?
- How much cash flow does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454547 have monthly?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20acquired%20resistance%20to%20first-%20and%20second-generation%20EGFR%20tyrosine%20kinase%20inhibitors&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdx703&volume=29&pages=i10-i19&publication_year=2018&author=Westover%2CD&author=Zugazagoitia%2CJ&author=Cho%2CBC&author=Lovly%2CCM&author=Paz-Ares%2CL earns monthly
- https://doi.org/10.1080%2F14737140.2017.1355243's financial summary
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28701107
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Overcoming%20resistance%20to%20EGFR%20tyrosine%20kinase%20inhibitors%20in%20lung%20cancer%2C%20focusing%20on%20non-T790M%20mechanisms&journal=Expert%20Rev%20Anticancer%20Ther&doi=10.1080%2F14737140.2017.1355243&volume=17&issue=9&pages=779-786&publication_year=2017&author=Suda%2CK&author=Rivard%2CCJ&author=Mitsudomi%2CT&author=Hirsch%2CFR?
- What's the financial outcome of https://doi.org/10.1158%2F0008-5472.CAN-13-3724?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25125655
- Find out how much http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263272 earns monthly
- How much profit is http://scholar.google.com/scholar_lookup?&title=EGFR%20blockade%20enriches%20for%20lung%20cancer%20stem-like%20cells%20through%20Notch3-dependent%20signaling&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-13-3724&volume=74&pages=5572-5584&publication_year=2014&author=Arasada%2CRR&author=Amann%2CJM&author=Rahman%2CMA&author=Huppert%2CSS&author=Carbone%2CDP making per month?
- What's the income generated by https://doi.org/10.1371%2Fjournal.pone.0107142 each month?
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25216266
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162571 earn?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=ALDH1A1%20maintains%20ovarian%20cancer%20stem%20cell-like%20properties%20by%20altered%20regulation%20of%20cell%20cycle%20checkpoint%20and%20DNA%20repair%20network%20signaling&journal=PLoS%20One&doi=10.1371%2Fjournal.pone.0107142&volume=9&issue=9&publication_year=2014&author=Meng%2CE&author=Mitra%2CA&author=Tripathi%2CK?
- How much cash flow does https://doi.org/10.1016%2Fj.biocel.2016.07.017 have monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27443528 net monthly?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20ALDH1A1%20activity%20decreases%20expression%20of%20drug%20transporters%20and%20reduces%20chemotherapy%20resistance%20in%20ovarian%20cancer%20cell%20lines&journal=Int%20J%20Biochem%20Cell%20Biol&doi=10.1016%2Fj.biocel.2016.07.017&volume=78&pages=248-259&publication_year=2016&author=Januchowski%2CR&author=Wojtowicz%2CK&author=Sterzy%C5%BFska%2CK&author=Sosi%C5%BFska%2CP&author=Andrzejewska%2CM&author=Zawierucha%2CP&author=Nowicki%2CM&author=Zabel%2CM?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21818590
- How much does http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20aldehyde%20dehydrogenase%20%28ALDH%29%20activity%20reduces%20chemotherapy%20and%20radiationresistance%20of%20stem-like%20ALDHhiCD44%2B%20human%20breast%20cancer%20cells&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-011-1692-y&volume=133&issue=1&pages=75-87&publication_year=2012&author=Croker%2CAK&author=Allan%2CAL pull in?
- How much revenue does https://doi.org/10.1016%2Fj.tips.2019.08.002 produce monthly?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31515079 each month?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Aldehyde%20dehydrogenase%20inhibitors%20for%20Cancer%20therapeutics&journal=Trends%20Pharmacol%20Sci&doi=10.1016%2Fj.tips.2019.08.002&volume=40&issue=10&pages=774-789&publication_year=2019&author=Dinavahi%2CSS&author=Bazewicz%2CCG&author=Gowda%2CR&author=Robertson%2CGP
- How much does https://doi.org/10.1038%2Fs41419-018-0903-4 net monthly?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30166520?
- How much money does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117306 make?
- http://scholar.google.com/scholar_lookup?&title=High%20NRF2%20level%20mediates%20cancer%20stem%20cell-like%20properties%20of%20aldehyde%20dehydrogenase%20%28ALDH%29-high%20ovarian%20cancer%20cells%3A%20inhibitory%20role%20of%20all-trans%20retinoic%20acid%20in%20ALDH%2FNRF2%20signaling&journal=Cell%20Death%20Dis&doi=10.1038%2Fs41419-018-0903-4&volume=9&issue=9&publication_year=2018&author=Kim%2CD&author=Choi%2CBH&author=Ryoo%2CIG&author=Kwak%2CMK income
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27942929?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Use%20of%20retinoic%20acid%2Faldehyde%20dehydrogenase%20pathway%20as%20potential%20targeted%20therapy%20against%20cancer%20stem%20cells&journal=Cancer%20Chemother%20Pharmacol&doi=10.1007%2Fs00280-016-3213-5&volume=79&issue=2&pages=295-301&publication_year=2017&author=Moreb%2CJS&author=Ucar-Bilyeu%2CDA&author=Khan%2CA earns monthly
- Get to know what's the income of https://doi.org/10.1093%2Fjnci%2F91.12.1059
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10379969
- What's the income of http://scholar.google.com/scholar_lookup?&title=Expression%20of%20retinoid%20receptor%20genes%20and%20proteins%20in%20non-small-cell%20lung%20cancer&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2F91.12.1059&volume=91&issue=12&pages=1059-1066&publication_year=1999&author=Picard%2CE&author=Seguin%2CC&author=Monhoven%2CN&author=Rochette-Egly%2CC&author=Siat%2CJ&author=Borrelly%2CJ&author=Martinet%2CY&author=Martinet%2CN&author=Vignaud%2CJM?
- What's the total monthly financial gain of https://doi.org/10.1002%2F%28SICI%291097-0215%2819980105%2975%3A1%3C88%3A%3AAID-IJC14%3E3.0.CO%3B2-9?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9426695 rake in every month?
- http://scholar.google.com/scholar_lookup?&title=Regulation%20of%20RAR%20beta%20expression%20by%20RAR-and%20RXR-selective%20retinoids%20in%20human%20lung%20cancer%20cell%20lines%3A%20effect%20on%20growth%20inhibition%20and%20apoptosis%20induction&journal=Int%20J%20Cancer&doi=10.1002%2F%28SICI%291097-0215%2819980105%2975%3A1%3C88%3A%3AAID-IJC14%3E3.0.CO%3B2-9&volume=75&issue=1&pages=88-95&publication_year=1998&author=Li%2CY&author=Dawson%2CMI&author=Agadir%2CA&author=Lee%2CMO&author=Jong%2CL&author=Hobbs%2CPD&author=Zhang%2CXK's financial summary
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27306217 income
- How much money does http://scholar.google.com/scholar_lookup?&title=Association%20between%20nuclear%20expression%20of%20retinoic%20acid%20receptor%20alpha%20and%20beta%20and%20clinicopathological%20features%20and%20prognosis%20of%20advanced%20non-small%20cell%20lung%20cancer&journal=Int%20J%20Clin%20Oncol&doi=10.1007%2Fs10147-016-1002-0&volume=21&issue=6&pages=1051-1061&publication_year=2016&author=Mu%C3%B1iz-Hern%C3%A1ndez%2CS&author=Huerta-Yepez%2CS&author=Hern%C3%A1ndez-Pedro%2CN&author=Ram%C3%ADrez-Tirado%2CLA&author=Aviles-Salas%2CA&author=Maldonado%2CA make?
- Get to know what's the income of https://doi.org/10.1111%2Fcas.12749
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26202045
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4638008 make?
- How much money does http://scholar.google.com/scholar_lookup?&title=Acquisition%20of%20cancer%20stem%20cell-like%20properties%20in%20non-small%20cell%20lung%20cancer%20with%20acquired%20resistance%20to%20afatinib&journal=Cancer%20Sci&doi=10.1111%2Fcas.12749&volume=106&pages=1377-1384&publication_year=2015&author=Hashida%2CS&author=Yamamoto%2CH&author=Shien%2CK generate?
- How much does https://doi.org/10.1158%2F1541-7786.MCR-08-0393 earn?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19276181 generate monthly?
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255559 generate?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Aldehyde%20dehydrogenase%201%20is%20a%20tumor%20stem%20cell-associated%20marker%20in%20lung%20cancer&journal=Mol%20Cancer%20Res&doi=10.1158%2F1541-7786.MCR-08-0393&volume=7&pages=330-338&publication_year=2009&author=Jiang%2CF&author=Qiu%2CQ&author=Khanna%2CA&author=Todd%2CNW&author=Deepak%2CJ&author=Xing%2CL generate?
- How much profit does https://doi.org/10.1016%2Fj.canlet.2012.08.021 make?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22935675?
- Income figures for http://scholar.google.com/scholar_lookup?&title=ALDH-positive%20lung%20cancer%20stem%20cells%20confer%20resistance%20to%20epidermal%20growth%20factor%20receptor%20tyrosine%20kinase%20inhibitors&journal=Cancer%20Lett&doi=10.1016%2Fj.canlet.2012.08.021&volume=328&pages=144-151&publication_year=2013&author=Huang%2CCP&author=Tsai%2CMF&author=Chang%2CTH&author=Tang%2CWC&author=Chen%2CSY&author=Lai%2CHH
- How much does https://doi.org/10.1158%2F0008-5472.CAN-13-3456 gross monthly?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24812274 earns monthly
- How much does http://scholar.google.com/scholar_lookup?&title=The%20cancer%20cell%20marker%20aldehyde%20dehydrogenase%20is%20required%20to%20maintain%20a%20drug-tolerant%20tumor%20cell%20subpopulation&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-13-3456&volume=74&pages=3579-3590&publication_year=2014&author=Raha%2CD&author=Wilson%2CTR&author=Peng%2CJ&author=Peterson%2CD&author=Yue%2CP&author=Evangelista%2CM&author=Wilson%2CC&author=Merchant%2CM&author=Settleman%2CJ pull in?
- Get to know what's the income of https://doi.org/10.1002%2Fjcp.22417
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20836077
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315372
- Earnings of http://scholar.google.com/scholar_lookup?&title=Retinoids%20regulate%20stem%20cell%20differentiation&journal=J%20Cell%20Physiol&doi=10.1002%2Fjcp.22417&volume=226&pages=322-330&publication_year=2011&author=Gudas%2CLJ&author=Wagner%2CJA
- Revenue of https://doi.org/10.1124%2Fjpet.104.072496
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15470086
- Income figures for http://scholar.google.com/scholar_lookup?&title=Retinoic%20acid%20downregulates%20aldehyde%20dehydrogenase%20and%20increases%20cytotoxicity%20of%204-hydroperoxycyclophosphamide%20and%20acetaldehyde&journal=J%20Pharmacol%20Exp%20Ther&doi=10.1124%2Fjpet.104.072496&volume=312&pages=339-345&publication_year=2005&author=Moreb%2CJS&author=Gabr%2CA&author=Vartikar%2CGR&author=Gowda%2CS&author=Zucali%2CJR&author=Mohuczy%2CD
- Learn about the earnings of https://doi.org/10.1038%2Fs41467-018-03877-7
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29643385
- Learn how profitable http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895803 is on a monthly basis
- Revenue of http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20cancer%20stem%20cell%20like%20cells%20by%20a%20synthetic%20retinoid&journal=Nat%20Commun&doi=10.1038%2Fs41467-018-03877-7&volume=9&publication_year=2018&author=Chen%2CJ&author=Cao%2CX&author=An%2CQ&author=Zhang%2CY&author=Li%2CK&author=Yao%2CW
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Modulation%20of%20breast%20cancer%20stem%20cell%20marker%20CD44%20by%20all-trans-retinoic%20acid%20%28ATRA%29&journal=Cancer%20Res&volume=74&publication_year=2014&author=Kitadai%2CR&author=Bednarczyk%2CR&author=Tuli%2CN&author=Tiwari%2CRK
- How much income does https://doi.org/10.1016%2Fj.bcp.2008.10.011 have?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18992716 earns monthly
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Retinoic%20acid%20modulates%20retinaldehyde%20dehydrogenase%201%20gene%20expression%20through%20the%20induction%20of%20GADD153-C%20%2FEBPbeta%20interaction&journal=Biochem%20Pharmacol&doi=10.1016%2Fj.bcp.2008.10.011&volume=77&pages=248-257&publication_year=2009&author=Elizondo%2CG&author=Medina-D%C3%ADaz%2CIM&author=Cruz%2CR&author=Gonzalez%2CFJ&author=Vega%2CL produce monthly?
- How much cash flow does https://doi.org/10.1074%2Fjbc.M004987200 have monthly?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10995752
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Feedback%20inhibition%20of%20the%20retinaldehyde%20dehydrogenase%20gene%20ALDH1%20by%20retinoic%20acid%20through%20retinoic%20acid%20receptor%20alpha%20and%20CCAAT%2Fenhancer-binding%20protein%20beta&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.M004987200&volume=275&pages=39747-39753&publication_year=2000&author=Elizondo%2CG&author=Corchero%2CJ&author=Sterneck%2CE&author=Gonzalez%2CFJ
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12012012 net monthly?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=All%20trans%20retinoic%20acid%20enhances%20CDDP-induced%20apoptosis%3A%20modulation%20of%20the%20CDDP%20effect%20on%20cell%20cycle%20progression&journal=Int%20J%20Oncol&volume=20&pages=1289-1295&publication_year=2002&author=Jozan%2CS&author=Paute%2CS&author=Courtade-Sa%C3%AFdi%2CM&author=Juli%C3%A9%2CS&author=Vidal%2CS&author=Bugat%2CR&author=Valette%2CA
- How much does https://doi.org/10.1038%2Fsj.onc.1207040 gross monthly?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14724571
- Monthly income for http://scholar.google.com/scholar_lookup?&title=All-trans%20retinoic%20acid%20potentiates%20Taxotere%20induced%20cell%20death%20mediated%20by%20Jun%20N-terminal%20kinase%20in%20breast%20cancer%20cells&journal=Oncogene.&doi=10.1038%2Fsj.onc.1207040&volume=23&pages=426-433&publication_year=2004&author=Wang%2CQ&author=Wieder%2CR
- What is the earnings of https://doi.org/10.1016%2Fj.mam.2014.12.003?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Retinoic%20acid%20receptors%3A%20from%20molecular%20mechanisms%20to%20cancer%20therapy&journal=Mol%20Asp%20Med&doi=10.1016%2Fj.mam.2014.12.003&volume=41&pages=1-115&publication_year=2015&author=Masi%2CA&author=Leboffe%2CL&author=Marinis%2CE&author=Pagano%2CF&author=Cicconi%2CL&author=Rochette-Egly%2CC&author=Lo-Coco%2CF&author=Ascenzi%2CP&author=Nervi%2CC make?
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20507312?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907750?
- How much does http://scholar.google.com/scholar_lookup?&title=All%20trans%20retinoic%20acid%20nanodisks%20enhance%20retinoic%20acid%20receptor%20mediated%20apoptosis%20and%20cell%20cycle%20arrest%20in%20mantle%20cell%20lymphoma&journal=Br%20J%20Haematol&volume=150&pages=158-169&publication_year=2010&author=Singh%2CAT&author=Evens%2CAM&author=Anderson%2CRJ&author=Beckstead%2CJA&author=Sankar%2CN&author=Sassano%2CA&author=Bhalla%2CS&author=Yang%2CS&author=Platanias%2CLC&author=Forte%2CTM&author=Ryan%2CRO&author=Gordon%2CLI net monthly?
- https://doi.org/10.1016%2FS0006-2952%2899%2900355-X's total income per month
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10660115 bring in?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Differential%20effects%20of%20retinoic%20acid%20on%20growth%20and%20apoptosis%20in%20human%20colon%20cancer%20cell%20lines%20associated%20with%20the%20induction%20of%20retinoic%20acid%20receptor%20beta&journal=Biochem%20Pharmacol&doi=10.1016%2FS0006-2952%2899%2900355-X&volume=59&pages=485-496&publication_year=2000&author=Lee%2CMO&author=Han%2CSY&author=Jiang%2CS&author=Park%2CJH&author=Kim%2CSJ making per month?
- What are the total earnings of https://doi.org/10.1016%2Fj.phrs.2019.104331?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31254665's financial summary
- Earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066582
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=The%20potential%20of%20retinoids%20for%20combination%20therapy%20of%20lung%20cancer%3A%20updates%20and%20future%20directions&journal=Pharmacol%20Res&doi=10.1016%2Fj.phrs.2019.104331&volume=147&publication_year=2019&author=Tripathi%2CSK&author=Pandey%2CK&author=Panda%2CM&author=Spinella%2CMJ&author=Rengasamy%2CKR&author=Biswal%2CBK?
- What's the profit of https://doi.org/10.1093%2Fcarcin%2Fbgi006?
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15618235?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Comprehensive%20expression%20analysis%20of%20retinoic%20acid%20receptors%20and%20retinoid%20X%20receptors%20in%20non-small%20cell%20lung%20cancer%3A%20implications%20for%20tumor%20development%20and%20prognosis&journal=Carcinogenesis.&doi=10.1093%2Fcarcin%2Fbgi006&volume=26&pages=525-530&publication_year=2005&author=Brabender%2CJ&author=Metzger%2CR&author=Salonga%2CD&author=Danenberg%2CKD&author=Danenberg%2CPV&author=H%C3%B6lscher%2CAH&author=Schneider%2CPM
- How much income is https://doi.org/10.1016%2FS1359-6349%2803%2900010-7 earning monthly?
- How much income is http://scholar.google.com/scholar_lookup?&title=Retinoids%20and%20retinoic%20acid%20receptor%20in%20cancer&journal=Eur%20J%20Cancer%20Suppl&doi=10.1016%2FS1359-6349%2803%2900010-7&volume=1&pages=13-18&publication_year=2003&author=Lei%2CM&author=Th%C3%A9%2CH earning monthly?
- What's the financial gain of https://doi.org/10.1093%2Fjnci%2F89.9.624?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9150186?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Suppression%20of%20nuclear%20retinoic%20acid%20receptor%20%CE%B2%20in%20non-small%20cell%20lung%20cancer%20in%20vivo%3A%20implications%20in%20lung%20cancer%20development&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2F89.9.624&volume=89&pages=624-629&publication_year=1997&author=Xu%2CXC&author=Sozzi%2CG&author=Lee%2CJS&author=Lee%2CJJ&author=Pastorino%2CU&author=Pilotti%2CS&author=Kurie%2CJM&author=Hong%2CWK&author=Lotan%2CR?
- Monthly income for https://doi.org/10.1038%2Fs41598-017-05047-z
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28684780?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500497
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Retinoic%20Acid%20affects%20Lung%20Adenocarcinoma%20growth%20by%20inducing%20differentiation%20via%20GATA6%20activation%20and%20EGFR%20and%20Wnt%20inhibition&journal=Sci%20Rep&doi=10.1038%2Fs41598-017-05047-z&volume=7&publication_year=2017&author=Zito%2CG&author=Naselli%2CF&author=Saieva%2CL&author=Raimondo%2CS&author=Calabrese%2CG&author=Guzzardo%2CC&author=Forte%2CS&author=Rolfo%2CC&author=Parenti%2CR&author=Alessandro%2CR?
- What's the monthly income of https://citation-needed.springer.com/v2/references/10.1186/s12885-020-06818-0?format=refman&flavour=references?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Wenxiu%20Yao's revenue stream
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Wenxiu%20Yao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Liyang%20Wang?
- What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Liyang%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Huan%20Huang generate?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Huan%20Huang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xin%20Li
- Earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xin%20Li%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Pinjia%20Wang bring in each month?
- Earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Pinjia%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kun%20Mi?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kun%20Mi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jia%20Cheng
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jia%20Cheng%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in each month?
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Huifen%20Liu?
- What is the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Huifen%20Liu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Cuirong%20Gu
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Cuirong%20Gu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Lingxiao%20Huang
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Lingxiao%20Huang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en gross monthly?
- Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jianming%20Huang
- How much cash flow does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jianming%20Huang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have monthly?
- How much revenue does https://static-content.springer.com/esm/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_MOESM1_ESM.jpg generate?
- Profit of https://static-content.springer.com/esm/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_MOESM2_ESM.jpg
- https://static-content.springer.com/esm/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_MOESM3_ESM.jpg's revenue stream
- How much does http://creativecommons.org/licenses/by/4.0/ bring in each month?
- How much does http://creativecommons.org/publicdomain/zero/1.0/ generate monthly?
- How much does https://s100.copyright.com/AppDispatchServlet?title=All-trans%20retinoic%20acid%20reduces%20cancer%20stem%20cell-like%20cell-mediated%20resistance%20to%20gefitinib%20in%20NSCLC%20adenocarcinoma%20cells&author=Wenxiu%20Yao%20et%20al&contentID=10.1186%2Fs12885-020-06818-0©right=The%20Author%28s%29&publication=1471-2407&publicationDate=2020-04-15&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY%20%2B%20CC0 generate monthly?
- How much revenue does https://crossmark.crossref.org/dialog/?doi=10.1186/s12885-020-06818-0 bring in?
- Earnings of https://citation-needed.springer.com/v2/references/10.1186/s12885-020-06818-0?format=refman&flavour=citation
- Revenue of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
- Income figures for https://www.springernature.com/gp/products
- How much does https://www.springernature.com/gp/librarians generate monthly?
- What's the financial gain of https://www.springernature.com/gp/societies?
- Check the income stats for https://www.springernature.com/gp/partners
- https://www.springer.com/'s financial summary
- What's https://www.nature.com/'s gross income?
- How profitable is https://www.biomedcentral.com/?
- What's the income of https://www.palgrave.com/?
- Income figures for https://www.apress.com/
- Learn about the earnings of https://www.springernature.com/gp/legal/ccpa
- Profit of https://www.springernature.com/gp/info/accessibility
- What's the income of https://support.springernature.com/en/support/home?
- What's the financial intake of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
- How much does https://www.springernature.com/ rake in every month?
Analytics and Tracking {š}
- Google Tag Manager
Libraries {š}
- Clipboard.js
- Prism.js
CDN Services {š¦}
- Crossref